Experts said markets overcame global jitters due to US-China trade war and turned their focus on the Lok Sabha election 2019.

Some of the generic companies, it points out, made unsolicited bids to customers of bigger players in cases where drug prices were high as a way to compete with a bigger generic player to grab a bigger share in the market. Interestingly, this exercise seems to have elements of attempts at trying to drive down prices to gain customers.

India postpones retaliatory tariff deadline on US products to Jun 16, RBI needs to go for larger rate cut in next monetary policy review, Indian firm Glenmark may face a penalty of up to $873 million and other news on News Blast.

After Cognizant, IBM India fires 300 employees from services divisionTech behemoth IBM India has reportedly fired nearly 300 employees from its services division as it looks to \"re-invent\" its operations and fulfill the changing demand of the customers. The US-based IT major let these employees go as it focuses on emerging technology like Artificial Intelligence and reduces exposure to traditional services. US pharma scandal: Indian firm Glenmark may face a penalty of up to $873 millio...

Share Market Updates: Shedding gains of the trading session Wednesday, benchmark indices closed in the red. Other major indices gave up all intraday gains to turn negative in trade as well.

In separate clarifications to stock exchanges, the companies denied the accusations and stated they would defend themselves in the matter

Severe penalties could be levied on the Indian pharma companies varying from $13 million to $873 million; Glenmark could face the highest penalty, while Aurobindo the least.

The ongoing trade war between the US and China had triggered the recent correction in the market

The lawsuit accuses Teva Pharmaceuticals USA Inc of orchestrating a sweeping scheme with 19 other companies to inflate drug prices, by more than 1,000% in some cases

Markets Live: While Sensex is trading 263 points higher at 37,354, Nifty is up 83 points to 11,231.70. Sun Pharma, Vedanta and ICICI Bank were the top gainers on Sensex. Tata Steel, Bajaj Auto and Asian Paints were the top losers on Sensex.

Sun Pharma shares dived 9.39 per cent to close at Rs 396.85 on the BSE

Glenmark calls itself, \"the first company in the world to launch the novel SGLT2 inhibitor Remogliflozin and India, the first country to get access to this innovative drug